The PDX AML samples were all sensitive to USP15 inhibition as the leukemic progenitor function was reduced by greater than 90% for all samples treated with USP15-Inh relative to control cells (Fig. 6F, G). This evidence concerns the gene USP15 and acute myeloid leukemia.